ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,065Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 337

$690K Total Retail Price of All Prescriptions

Rank: 29 out of 337

479 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 479 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 15,089 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 976 910 1 11
LISINOPRIL 791 777 2 2
LEVOTHYROXINE SODIUM 628 566 3 5
AMLODIPINE BESYLATE 546 543 4 3
OMEPRAZOLE 486 449 5 4
METOPROLOL TARTRATE 467 430 6 6
ATENOLOL 411 400 7 10
ATORVASTATIN CALCIUM 394 381 8 7
ALENDRONATE SODIUM 372 356 9 19
FUROSEMIDE 368 368 10 8
PRAVASTATIN SODIUM 351 343 11 14
SIMVASTATIN 297 275 12 1
TRAZODONE HCL 266 265 13 16
HYDROCHLOROTHIAZIDE 258 253 14 9
DONEPEZIL HCL 248 239 15 22
LOVASTATIN 247 226 16 24
CITALOPRAM HBR 243 241 17 17
GABAPENTIN 231 206 18 20
METOPROLOL SUCCINATE 201 201 19 21
MIRTAZAPINE 178 178 20 27
PAROXETINE HCL 175 156 21 46
METFORMIN HCL 169 152 22 12
RISPERIDONE 159 143 23 72
SERTRALINE HCL 157 124 24 18
PANTOPRAZOLE SODIUM 139 116 25 36
RANITIDINE HCL 138 138 26 30
POLYETHYLENE GLYCOL 3350 138 137 26 47
DIOVAN 131 119 28 26
FELODIPINE ER 129 129 29 79
MECLIZINE HCL 121 120 30 117
NAMENDA 120 120 31 35
CLOZAPINE 119 91 32 94
IPRATROPIUM-ALBUTEROL 110 98 33 96
CARBIDOPA-LEVODOPA 110 99 33 92
GLIPIZIDE 110 110 33 45
ESCITALOPRAM OXALATE 106 93 36 66
MELOXICAM 104 104 37 54
DIGOXIN 100 100 38 58
PREDNISONE 98 95 39 40
GEMFIBROZIL 97 85 40 114
LOSARTAN POTASSIUM 94 94 41 15
SPIRIVA 90 90 42 43
ALLOPURINOL 89 88 43 28
TRIAMTERENE-HCTZ 85 84 44 39
ALBUTEROL SULFATE 84 42 45 131
HYDROCODONE-ACETAMINOPHEN 84 83 S3 45 13
QUETIAPINE FUMARATE 83 69 47 61
CLOPIDOGREL 82 81 48 42
LEVOFLOXACIN 76 71 49 93
NYSTOP 72 69 50 140
LANTUS 71 48 51 49
DILTIAZEM ER 68 60 52 169
DILTIAZEM 24HR ER 64 64 53 76
POTASSIUM CHLORIDE 63 63 54 62
PROAIR HFA 63 61 54 38
TAMSULOSIN HCL 62 62 56 25
PROPRANOLOL HCL 61 61 57 121
KLOR-CON M20 60 59 58 65
ISOSORBIDE MONONITRATE ER 60 47 58 70
LIDODERM 60 60 58 82
CIPROFLOXACIN HCL 59 55 61 71
PLAVIX 59 59 61 74
CLONIDINE HCL 58 58 63 135
TRAMADOL HCL 57 56 64 32
CYMBALTA 55 55 65 59
CRESTOR 55 49 65 29
FENTANYL 53 53 S2 67 138
LIPITOR 53 53 67 33
AZITHROMYCIN 53 51 67 51
FLUTICASONE PROPIONATE 52 36 70 34
GALANTAMINE HBR 50 50 71 234
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.